We engineer multifunctional nanoparticles tailored for precise tumor targeting in cancer therapy. By leveraging active receptor targeting and smart stimulus-responsive mechanisms, our nanomedicine platforms efficiently penetrate tumor microenvironments. This approach ensures maximal drug accumulation directly within cancer cells while minimizing off-target side effects for safer and high-efficacy oncology treatments.

We develop innovative non-invasive delivery platforms targeting intranasal, oromucosal, and pulmonary routes. By engineering mucosal-adhesive formulations and aerosolizable nanocarriers, our systems overcome epithelial barriers to achieve rapid mucosal absorption and direct lung targeting, enabling highly efficient, non-systemic therapeutics for systemic and respiratory disorders.